Ovarian Cysts Market Research Report: By Type (Functional Cysts, Non-Functional Cysts) By Diagnosis (Imaging, CA-125 Blood Test, Laparoscopy) By Treatment (PCOS Drugs, Surgery) By End Users (Hospitals, Research Organization) - Global Forecast till 2023

Pune, India -- (SBWire) -- 02/28/2018 --Ovarian cysts are closed, sac-like structures filled with a liquid or semisolid substance within the ovary. The formation of ovarian cysts in ovulating females is common. However, if the formation of ovarian cysts occurs after the menopause, then a high risk for the development of the ovarian cancer is suspected. Increasing prevalence of the ovarian cysts is likely to drive the market growth during the forecast period.

The Global Ovarian Cysts Market are expected to grow at an approximate CAGR of 8.2% during the forecast period.

According to a study published in the Journal of Clinical Research in Pediatric Endocrinology in 2017, the frequency of ovarian cysts is about 1.8% in children aged between 5-9 years and 18.8% in those who aged between 10-18 years.

Moreover, it is estimated that with the onset of adolescence and increasing age, the frequency of ovarian cysts increases and ranges in between 3.8%-31.3%. Moreover, rising healthcare expenditures, increasing awareness about woman health are projected to boost the market growth during the forecast period. However, lack of awareness and low per capita healthcare expenditure in the developing countries may hamper the market growth.

Key players in global ovarian cysts market

Pfizer Inc. (U.S.),
Teva Pharmaceutical Industries Ltd. (The Middle East & Africa),
Quest Diagnostics Incorporated. (U.S.),
Novartis AG (Europe),
General Electric Company (Europe),
Merck & Co., Inc. (U.S.),
Boston Scientific Corporation (U.S.),
Medtronic (U.S)

Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/1784 .

Segmentation:

The global ovarian cysts market is segmented on the basis of type, diagnosis, treatment, and end users.

On the basis of the type, the market is segmented into functional cysts, non-functional cysts, and others. The functional cysts segment by type is sub-segmented into the follicular cyst, corpus luteum cyst, and others. The non-functional cysts segment by type is sub-segmented into dermoid cysts, cystadenomas, endometriomas, and others.

On the basis of the diagnosis, the market is segmented into imaging, CA-125 blood test, laparoscopy, and others. The imaging segment is sub-segmented into CT scan, MRI, ultrasound, and others.

On the basis of the treatment, the market is segmented into medication, polycystic ovary syndrome (PCOS) drugs, pain relievers, surgery, and others. The pain relievers are sub-segmented into acetaminophen, non-steroidal anti-inflammatory drugs, opioids, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.

Brief TOC

1 Report Prologue

2 Introduction

2.1 Definition
2.2 Scope of the Study
2.3 Research Objective
2.4 Assumptions
2.5 Limitations
2.6 Market Structure
2.7 Market Segmentation

Get Attractive Discount @ https://www.marketresearchfuture.com/check-discount/1784 .

3 Research Methodology

3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model

4 Market Dynamics

…TOC Continued

About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.